For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Whether looking to pamper yourself or grab a little gift for your BFF, sheet masks are an easy beauty buy that is sure to please. Equal parts skin care and self-care, a sheet mask probably won’t make ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

BSX carries a Zacks Rank #2 (Buy), while RMD has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 ...

Paul Hunter consults for the World Health Organization. He receives funding from National Institute for Health Research and has received funding from the World Health Organization and the European ...

LED face masks offer a host of transformative skin benefits—they can reduce redness, treat acne, and minimize the look of fine lines, wrinkles, and discoloration. Even better, they don’t require a lot ...

ResMed Inc. (NYSE:RMD) reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

Evidence continues to mount that mask mandates were perhaps the worst public-health intervention in modern American history. While concluding that wearing masks “probably makes little or no difference ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? I picked up my first weighted sleep mask years ago, hoping it would help me ...

ResMed's fourth-quarter fiscal 2025 underlying EBIT grew 7% on the third, driven by increased product demand and gross margin expanding 150 basis points to 61% on component cost improvements and a ...